BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cooper E, Choi PJ, Denny WA, Jose J, Dragunow M, Park TI. The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors. Front Oncol 2021;11:654921. [PMID: 34141613 DOI: 10.3389/fonc.2021.654921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Muangsopa P, Chansaenpak K, Kampaengsri S, Saetiew J, Noisa P, Meemon P, Kamkaew A. Hybrid Cyanine/Methotrexate Nanoparticles for Synergistic PDT/Chemotherapy of Breast Cancer. ACS Appl Bio Mater 2023. [PMID: 36621814 DOI: 10.1021/acsabm.2c00893] [Reference Citation Analysis]
2 Jo G, Kim EJ, Hyun H. Enhanced Tumor Uptake and Retention of Cyanine Dye-Albumin Complex for Tumor-Targeted Imaging and Phototherapy. Int J Mol Sci 2023;24. [PMID: 36614318 DOI: 10.3390/ijms24010862] [Reference Citation Analysis]
3 Brar HK, Jose J, Wu Z, Sharma M. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery. Pharmaceutics 2022;15. [PMID: 36678688 DOI: 10.3390/pharmaceutics15010059] [Reference Citation Analysis]
4 Broadwater D, C D Medeiros H, Bates M, Roshanzadeh A, Thing Teoh S, P Ogrodzinski M, Borhan B, Lunt RR, Lunt SY. Counterion Tuning of Near-Infrared Organic Salts Dictates Phototoxicity to Inhibit Tumor Growth. ACS Appl Mater Interfaces 2022;14:53511-22. [PMID: 36408853 DOI: 10.1021/acsami.2c16252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Veryutin DA, Doroshenko IA, Martynova EA, Sapozhnikova KA, Svirshchevskaya EV, Shibaeva AV, Markova AA, Chistov AA, Borisova NE, Shuvalov MV, Korshun VA, Alferova VA, Podrugina TA. Probing tricarbocyanine dyes for targeted delivery of anthracyclines. Biochimie 2022:S0300-9084(22)00251-6. [PMID: 36179940 DOI: 10.1016/j.biochi.2022.09.015] [Reference Citation Analysis]
6 Lim W, Byun JY, Jo G, Kim EJ, Park MH, Hyun H. Molecular Tuning of IR-786 for Improved Tumor Imaging and Photothermal Therapy. Pharmaceutics 2022;14:676. [DOI: 10.3390/pharmaceutics14030676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Choi PJ, Tomek P, Tercel M, Reynisson J, Park TIH, Cooper EA, Denny WA, Jose J, Leung E. Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action. Molecules 2022;27:880. [PMID: 35164144 DOI: 10.3390/molecules27030880] [Reference Citation Analysis]
8 Choi PJ, Cooper EA, Park TI, Denny WA, Jose J. Novel synthetic approach for accessing drug–dye conjugates for targeted tumour therapy. Results in Chemistry 2022;4:100343. [DOI: 10.1016/j.rechem.2022.100343] [Reference Citation Analysis]
9 Leung E, Tomek P, Tercel M, Reynisson J, Park T, Cooper E, Denny W, Choi P, Jose J. Conjugation of palbociclib with MHI-148 has an increased cytotoxic effect for breast cancer cells and an altered mechanism of action.. [DOI: 10.1101/2021.11.02.466693] [Reference Citation Analysis]